Skip to content 
AMM 115: Restylane SHAYPE: Galderma’s Game-Changer for Chin Augmentation
June 21, 2024
This episode covers the recent approval of Restylane® SHAYPE™ by Health Canada, a new hyaluronic acid injectable designed specifically for chin augmentation. Listeners will learn about the innovative NASHA HD™ technology that makes this the firmest HA injectable on the market, providing a non-surgical option that mimics the qualities of an implant. The episode delves into the compelling results from a 12-month study conducted across Canada, highlighting high satisfaction rates among participants. It also discusses the broader implications for aesthetic medicine and what this means for future non-surgical treatments.
Quick Takes
- Galderma received Health Canada’s approval for Restylane® SHAYPE™, a new hyaluronic acid injectable designed for chin augmentation.
- Restylane® SHAYPE™ uses NASHA HD™ technology, making it the firmest HA injectable on the market with a bone-mimicking effect for shaping the chin.
- A 12-month study in Canada showed that 91% of participants reported aesthetic improvements lasting a year, 84% would choose this product for future treatments, and 97% would recommend it to a friend due to natural-looking results.
Episode Transcript
Today is June 21, 2024. Exciting news in the world of aesthetic medicine. Galderma, a leader in the dermatology category, recently received Health Canada’s approval for their new hyaluronic acid injectable, Restylane® SHAYPE™. This product is specifically designed for chin augmentation.
Restylane® SHAYPE™ uses NASHA HD™ technology, making it the firmest HA injectable on the market. What sets this apart is its bone-mimicking effect, ideal for shaping, projecting, and elongating the chin.
In a 12-month study conducted at nine sites across Canada, results were compelling. A whopping 91% of participants reported aesthetic improvements lasting the full year. Also, 84% said they would choose Restylane® SHAYPE™ for future treatments. Perhaps most impressively, 97% would recommend it to a friend, and 95% felt their results looked natural.
As regulatory reviews continue worldwide, Galderma is working hard to bring this innovative product to more markets. If you’re looking to enhance your chin profile non-surgically, Restylane® SHAYPE™ may be worth exploring.
